STAMBP and dry eye syndrome: These studies indicate that α-MSH may have the potential to antagonize the pathogenic factors of the DED, particularly the aqueous-deficient subtype of the disease, without incurring undesired complications, thus it would be interesting to examine the protective effects of this peptide in a dry eye model.